ConquerAb
ConquerAb Inc. specializes in precision medicine by developing rapid diagnostics (disposable devices) to detect and mitigate antibody responses against protein-based therapies. Their innovative technology enables point-of-care and at-home testing using just one drop of blood in less than 15 minutes, facilitating immunogenicity comparisons, risk assessment, and personalized treatment strategies. They hold multiple patents and aim to improve safety and efficacy in biotherapeutic treatments and vaccination monitoring.
Industries
Nr. of Employees
small (1-50)
Products
Disposable rapid antibody diagnostic device
A disposable diagnostic device designed to detect antibodies against therapeutic proteins using a single drop of blood, intended for point-of-care and at-home use with results in under 15 minutes.
Disposable rapid antibody diagnostic device
A disposable diagnostic device designed to detect antibodies against therapeutic proteins using a single drop of blood, intended for point-of-care and at-home use with results in under 15 minutes.
Services
Biotechnology and diagnostics consulting
Advisory services covering biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics.
Biotechnology and diagnostics consulting
Advisory services covering biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics.
Expertise Areas
- Point-of-care diagnostic development
- Antibody immunogenicity monitoring and comparative analysis
- At-home diagnostic solutions
- Assay development for antibody detection
Key Technologies
- Rapid point-of-care immunoassays (disposable devices)
- Fingerstick whole-blood sampling
- At-home diagnostic formats
- Comparative immunogenicity analysis